JW PHARMACEUTICAL (001060) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, JW PHARMACEUTICAL (001060) reported revenue of 775.3 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025775.3 billion KRW94.5 billion KRW61.5 billion KRW[source]
2024719.4 billion KRW82.5 billion KRW65.0 billion KRW[source]
2023748.5 billion KRW100.3 billion KRW38.4 billion KRW[source]
2022684.4 billion KRW63.0 billion KRW29.9 billion KRW[source]
2021606.6 billion KRW31.2 billion KRW-1.4 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025595.9 billion KRW218.2 billion KRW377.8 billion KRW[source]
2024582.6 billion KRW245.1 billion KRW337.5 billion KRW[source]
2023620.5 billion KRW345.3 billion KRW275.2 billion KRW[source]
2022568.8 billion KRW319.9 billion KRW248.9 billion KRW[source]
2021553.1 billion KRW346.8 billion KRW206.3 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice